Bank of Nova Scotia Trust’s Merck MRK Stock Holding History

Bank of Nova Scotia Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$774K	Buy	6,438 +3,704	+135%	+$428K	0.07%	104
2025 Q4	$288K	Buy	+2,734	New	+$257K	0.03%	132
2024 Q2	–	Sell	-2,200	Closed	-$290K	–	142
2024 Q1	$290K	Hold	2,200	–	–	0.03%	115
2023 Q4	$240K	Sell	2,200 -200	-8%	-$20.8K	0.03%	122
2023 Q3	$247K	Sell	2,400 -500	-17%	-$53.9K	0.03%	121
2023 Q2	$335K	Sell	2,900 -653	-18%	-$74.1K	0.03%	113
2023 Q1	$378K	Sell	3,553 -2,909	-45%	-$314K	0.04%	110
2022 Q4	$717K	Sell	6,462 -1	-0%	-$102	0.08%	85
2022 Q3	$556K	Buy	6,463 +400	+7%	+$35.7K	0.06%	89
2022 Q2	$553K	Sell	6,063 -164	-3%	-$14.5K	0.06%	97
2022 Q1	$511K	Buy	6,227 +2,326	+60%	+$183K	0.04%	103
2021 Q4	$299K	Sell	3,901 -2	-0.1%	-$159	0.03%	119
2021 Q3	$293K	Sell	3,903 -6	-0.2%	-$456	0.03%	116
2021 Q2	$304K	Buy	3,909 +42	+1%	+$3.12K	0.03%	117
2021 Q1	$284K	Sell	3,867 -694	-15%	-$51.2K	0.03%	116
2020 Q4	$356K	Sell	4,561 -9,222	-67%	-$705K	0.04%	104
2020 Q3	$1.09M	Buy	13,783 +720	+6%	+$56.4K	0.13%	69
2020 Q2	$964K	Buy	13,063 +7,561	+137%	+$569K	0.14%	61
2020 Q1	$404K	Sell	5,502 -314	-5%	-$24.7K	0.06%	76
2019 Q4	$505K	Buy	5,816 +2	+0%	+$164	0.06%	76
2019 Q3	$467K	Sell	5,814 -17,452	-75%	-$1.4M	0.05%	77
2019 Q2	$1.86M	Sell	23,266 -7,409	-24%	-$567K	0.22%	55
2019 Q1	$2.44M	Sell	30,675 -4,134	-12%	-$309K	0.3%	52
2018 Q4	$2.54M	Buy	34,809 +1,114	+3%	+$78.6K	0.35%	50
2018 Q3	$2.28M	Sell	33,695 -255	-0.8%	-$16.2K	0.25%	56
2018 Q2	$1.97M	Sell	33,950 -1,293	-4%	-$72.9K	0.22%	57
2018 Q1	$1.83M	Buy	35,243 +1,142	+3%	+$61.7K	0.21%	58
2017 Q4	$1.83M	Sell	34,101 -6,145	-15%	-$341K	0.2%	58
2017 Q3	$2.46M	Buy	40,246 +3,398	+9%	+$206K	0.26%	59
2017 Q2	$2.25M	Sell	36,848 -439	-1%	-$26.7K	0.26%	56
2017 Q1	$2.26M	Sell	37,287 -5,631	-13%	-$342K	0.26%	53
2016 Q4	$2.41M	Sell	42,918 -42,343	-50%	-$2.48M	0.28%	54
2016 Q3	$5.08M	Sell	85,261 -26,269	-24%	-$1.54M	0.61%	38
2016 Q2	$6.13M	Buy	111,530 +4,899	+5%	+$261K	0.8%	28
2016 Q1	$5.38M	Sell	106,631 -33,751	-24%	-$1.65M	0.73%	33
2015 Q4	$7.08M	Buy	140,382 +15,300	+12%	+$771K	1.06%	21
2015 Q3	$5.89M	Buy	125,082 +26,814	+27%	+$1.42M	0.83%	31
2015 Q2	$5.41M	Buy	98,268 +1,591	+2%	+$89.2K	0.69%	34
2015 Q1	$5.3M	Buy	96,677 +1,581	+2%	+$89.5K	0.68%	37
2014 Q4	$5.15M	Sell	95,096 -2,159	-2%	-$120K	0.62%	37
2014 Q3	$5.5M	Buy	97,255 +5,055	+5%	+$284K	0.64%	33
2014 Q2	$5.15M	Buy	92,200 +867	+0.9%	+$47.3K	0.56%	38
2014 Q1	$4.95M	Buy	91,333 +550	+0.6%	+$28.5K	0.66%	34
2013 Q4	$4.33M	Buy	90,783 +25,152	+38%	+$1.15M	0.59%	32
2013 Q3	$2.98M	Buy	65,631 +16,023	+32%	+$732K	0.43%	46
2013 Q2	$2.25M	Buy	+49,608	New	+$2.22M	0.33%	54

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of Nova Scotia Trust's MRK Position: Q1 2026 in Review

Bank of Nova Scotia Trust increased its Merck (MRK) stake by 135% in Q1 2026, buying an estimated $428K and bringing the position to 6,438 shares worth $774K. The position accounts for 0.07% of the portfolio, ranked #104.

Bank of Nova Scotia Trust first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $7.08M in Q4 2015. 3,783 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Bank of Nova Scotia Trust held 6,438 shares of Merck worth $774K as of Q1 2026.
Bank of Nova Scotia Trust bought 3,704 Merck shares in Q1 2026, an estimated $428K.
Merck made up 0.07% of Bank of Nova Scotia Trust's portfolio in Q1 2026, its #104 holding.
Bank of Nova Scotia Trust first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
Bank of Nova Scotia Trust's Merck position peaked at $7.08M in Q4 2015.
3,783 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bank of Nova Scotia Trust's 13F filing for Q1 2026, filed 13 May 2026.